AbSci
  • About Us
  • Careers
  • News
  • Contact
  • Facebook
  • Twitter
  • Linkedin
Select Page
AbSci Appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board

AbSci Appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board

Oct 2, 2018 | Announcement

“It is rejuvenating to be working with a young and energetic company like AbSci. Their exciting technology not only has dramatic development, yield and production speed advantages for manufacture of complex biopharmaceuticals,” – Andrew J.S. Jones, D. Phil

Recent Posts

  • AbSci Announces Strategic Investment by Merck Global Health Innovation Fund
  • AbSci Enters Biologics Development Collaboration with Xyphos Biosciences, an Astellas Company
  • AbSci Announces Acquisition of Deep Learning Company Denovium
  • AbSci to Present at the 39th Annual J.P. Morgan Healthcare Conference
  • AbSci Announces Recent Additions to Board of Directors

Archives

  • February 2021
  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • January 2020
  • July 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • May 2018
  • February 2018
  • January 2018
  • December 2017
  • October 2017
  • August 2017
  • April 2017
  • January 2017
  • October 2016
  • August 2016
  • May 2016
  • April 2016
  • October 2015
SEE ARCHIVE

Categories

  • Announcement
  • Article
  • Award
  • Fundraising
  • News
  • Press
  • Uncategorized

Designed by Elegant Themes | Powered by WordPress